12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

  • Cellectar Biosciences CLRB shares increased by 3.84% to $1.08 during Tuesday's after-market session. This security traded at a volume of 844.4K shares come close, making up 85.62% of its average volume over the last 100 days. The market value of their outstanding shares is at $65.9 million.
  • Biolase BIOL stock moved upwards by 1.98% to $0.72. The company's market cap stands at $108.8 million.
  • Amicus Therapeutics FOLD shares increased by 1.93% to $11.6. At the close, Amicus Therapeutics's trading volume reached 60.9K shares. This is 2.86% of its average volume over the last 100 days. The market value of their outstanding shares is at $3.0 billion.
  • Celularity CELU shares moved upwards by 1.92% to $6.89. The market value of their outstanding shares is at $850.6 million.
  • Iterum Therapeutics ITRM stock moved upwards by 1.63% to $0.68. The market value of their outstanding shares is at $123.5 million.
  • Dynavax Technologies DVAX stock increased by 1.41% to $17.88. Dynavax Technologies's trading volume hit 138.7K shares by close, accounting for 4.17% of its average volume over the last 100 days. The market value of their outstanding shares is at $2.0 billion.

Losers

  • NeuroOne Medical Tech NMTC stock decreased by 4.81% to $5.15 during Tuesday's after-market session. The market value of their outstanding shares is at $61.8 million.
  • Cabaletta Bio CABA shares decreased by 3.5% to $10.5. The market value of their outstanding shares is at $262.2 million.
  • Soligenix SNGX shares declined by 2.76% to $1.06. The market value of their outstanding shares is at $42.5 million.
  • 180 Life Sciences ATNF stock decreased by 2.33% to $6.31. The market value of their outstanding shares is at $213.0 million.
  • AnPac Bio-Medical Science ANPC stock fell 2.18% to $3.59. The company's market cap stands at $50.6 million.
  • OptiNose OPTN stock decreased by 2.16% to $2.72. The company's market cap stands at $145.0 million.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!